'Egg Freezing Focus' is a series sharing new technologies and products shaping how egg freezing patients make decisions and what fertility clinics should know about them. Future Fertility's VIOLET™ is one of the first technologies built to give patients objective, individualized data about their own eggs, rather than population averages.
Standard of Care Today
As you know, counseling egg freezing patients still comes down largely to age and egg count, sometimes alongside AMH and antral follicle count going in. It's a reasonable proxy, but it's a population-level estimate applied to an individual patient, and two patients with the same age and the same number of eggs retrieved can have meaningfully different reproductive potential. That variation isn't visible at the time of freezing under current standard of care. Egg quality is inferred, not measured, until the eggs are thawed and used, often years later.
Egg freezing patients also don't behave like IVF patients in active treatment. They're usually planning years ahead, weighing a cycle against its cost, its odds, and what it buys them later. That makes them more likely to ask for data, compare clinics, and want a clear rationale for the decision before they make it. Standard counseling based on age and count alone often doesn't meet that bar.
What VIOLET™ Is
VIOLET™ is an AI model that analyzes images of mature eggs, taken routinely by embryologists after retrieval and before vitrification, so it requires no change to the retrieval procedure itself. Trained and validated on more than 650,000 oocyte images tied to real reproductive outcomes across 15+ countries, the model generates a patient-friendly report predicting each egg's developmental potential, including likelihood of reaching blastocyst stage, along with an overall estimate of the patient's chance of having a child using those eggs.
It's a complement to existing tools, not a replacement, but it adds a layer of personalization that age and count alone can't provide, and it moves quality assessment up to the time of freezing instead of the time of thaw.
Why It Matters for Patient Decision-Making
Egg freezing patients are already oriented toward planning and evaluation. They're freezing eggs precisely because they want optionality later. A report that gives them something concrete to reference, revisit, and bring into future conversations about additional cycles or family-building timelines fits how they already think, and it replaces some of the uncertainty inherent in freezing "for someday" with information they can act on now.
It also affects how patients choose where to freeze. Patients can now compare egg freezing clinics by whether they offer VIOLET™ using Freeze Health's Compare Clinics tool, which means VIOLET™ availability is becoming a search criterion in its own right, alongside cost and location, when patients decide which clinic to use.
What It Means for Clinics
VIOLET™ reports are already available in over 300 clinics globally, integrated into existing lab workflows. The only operational change is capturing egg images with the clinic's current microscope or time-lapse system before vitrification.
For REIs and fertility providers, VIOLET™ is a tool for more grounded counseling conversations grounded in the patient's own data rather than a reference population. For patients evaluating clinics, and increasingly researching them through tools like Freeze Health's Compare Clinics, it's becoming a factor in where they choose to freeze, which makes it a competitive consideration for clinics as much as a clinical one.
How to Implement It
Future Fertility's commercial model is flexible, typically structured as SaaS or usage-based pricing. Clinics decide how VIOLET™ fits into their practice, and many clinics working with Future Fertility offer VIOLET™ reports on every egg freezing cycle. Each clinic sets its own approach to how any associated costs are incorporated into its patient-facing pricing. Future Fertility provides implementation support, training, and educational resources as part of onboarding to help ensure a smooth rollout.
Bottom Line
Egg freezing patients want objective information to guide their decisions, not just averages. They want as much information as possible to feel well-informed, both for decisions now, like whether they need another cycle, and to set realistic expectations if they use the eggs later. VIOLET™ meets that desire for objective information, positioning your clinic as one that understands and serves the needs of egg freezing patients, now and in the future.
